Scott Lowe Explains How Cellular Senescence Acts as a Cancer Safety Valve

In a CSHL Leading Strand lecture, Scott Lowe describes how cells carrying oncogenic mutations such as RAS enter senescence rather than becoming cancerous unless further events empower them. He points to telomerase reactivation in cancer cells, inactivation of the tumour suppressors p53 and p16 in many human cancers, and senescent cells detectable in precancerous lesions. He frames senescence as a cancer-protective safety threshold, presented as a model rather than a settled conclusion.